
Sign up to save your podcasts
Or


This week, please join authors Charles Khouri and Clément Jambon-Barbara as well as Associate Editor Kelly Chin as they discuss the article "Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260330.77255
By Greg Hundley, MD and Peder Myhre, MD, PhD4.3
3030 ratings
This week, please join authors Charles Khouri and Clément Jambon-Barbara as well as Associate Editor Kelly Chin as they discuss the article "Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260330.77255

138 Listeners

319 Listeners

503 Listeners

163 Listeners

896 Listeners

300 Listeners

3,381 Listeners

136 Listeners

1,150 Listeners

196 Listeners

91 Listeners

518 Listeners

376 Listeners

436 Listeners

378 Listeners